Literature DB >> 18563179

Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing.

Christopher P Denton1, Korsa Khan, Rachel K Hoyles, Xu Shiwen, Patricia Leoni, Yunliang Chen, Mark Eastwood, David J Abraham.   

Abstract

Previous attempts to delete type II TGFbeta receptor (TbetaRII) in fibroblasts have precluded examination of adult mice due to early mortality. We have selectively deleted TbetaRII postnatally in differentiated connective tissue fibroblasts using an inducible Cre-Lox strategy. Tamoxifen-dependent Cre recombinase linked to a fibroblast-specific regulatory sequence from the proalpha2(I)collagen gene permitted deletion of floxed TbetaRII alleles. After postnatal deletion of TbetaRII in fibroblasts, healing of excisional skin wounds in adults showed markedly attenuated dermal scar formation, defective wound contraction and enhanced epidermal proliferation. These findings support a pivotal role for transforming growth factor beta (TGFbeta) signalling in fibroblasts in regulating normal skin wound healing. Explanted dermal fibroblasts from TbetaRII-null-fib mice showed impaired migration and did not generate normal contractile biomechanical forces in fixed collagen gels nor develop alpha-smooth muscle antigen-rich stress fibers in response to TGFbeta1. Surprisingly, some TGFbeta-regulated proteins, including connective tissue growth factor (CTGF), were basally upregulated in TbetaRII-null fibroblasts and this was dependent on extracellular signal-regulated kinase 1/2 activity in these cells. This suggests that other intracellular pathways regulating CTGF expression may partially compensate for disruption of TGFbeta signalling in fibroblasts. Together, our data confirm that expression of TbetaRII in differentiated dermal fibroblasts is essential for normal wound healing and demonstrate a critical role in the development and function of myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563179     DOI: 10.1038/jid.2008.171

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

1.  Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure.

Authors:  Magaly Martinez-Ferrer; Ali-Reza Afshar-Sherif; Consolate Uwamariya; Benoit de Crombrugghe; Jeffrey M Davidson; Neil A Bhowmick
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

Review 2.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

3.  Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids.

Authors:  Lauro R Soares-Lopes; Ione M Soares-Lopes; Lauro Ll Filho; Airlane P Alencar; Benedito B da Silva
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-17

Review 4.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

5.  Transgenic mouse technology in skin biology: inducible gene knockout in mice.

Authors:  Christian Günschmann; Elena Chiticariu; Bhavuk Garg; Merve Meliha Hiz; Yora Mostmans; Maria Wehner; Lukas Scharfenberger
Journal:  J Invest Dermatol       Date:  2014-07       Impact factor: 8.551

6.  Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.

Authors:  Biao Hu; Zhe Wu; Taku Nakashima; Sem H Phan
Journal:  Am J Pathol       Date:  2012-04-11       Impact factor: 4.307

7.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

8.  Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-β3 signaling.

Authors:  Zhong Zheng; Calvin Nguyen; Xinli Zhang; Hooman Khorasani; Joyce Z Wang; Janette N Zara; Franklin Chu; Wei Yin; Shen Pang; Anh Le; Kang Ting; Chia Soo
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

9.  Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.

Authors:  Emma C Derrett-Smith; Audrey Dooley; Korsa Khan; Xu Shi-wen; David Abraham; Christopher P Denton
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

10.  Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

Authors:  Andrew Leask; Sunil K Parapuram; Xu Shi-Wen; D J Abraham
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.